Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImpiloVest is a South African healthcare investment group that operates across the entire pharmaceutical and medical value chain. The company focuses on manufacturing, distribution, and retail of healthcare products, including specialty pharmaceuticals, medical devices, and medicinal cannabis. Through its subsidiary SpecPharm, ImpiloVest provides contract manufacturing and commercialization services for a wide range of therapeutic areas. The group aims to improve access to affordable, high-quality healthcare solutions across the African continent. Its integrated business model allows for end-to-end control of product development, from cultivation and extraction to final market delivery. ImpiloVest also emphasizes innovation in the medical cannabis sector, leveraging its extraction and manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImpiloVest.